Related Experiment Videos
Pustular impetigo with good response to clarithromycin
E Rallis1, A Nasiopoulou, E Tsiambas
1NIMTS Hospital, Department of Dermatology, Athens, Greece. efrall@otenet.gr
Drugs Under Experimental and Clinical Research
|July 27, 2004
Summary
This case report details an unusual pustular impetigo infection in a 35-year-old man, successfully treated with clarithromycin. The findings highlight clarithromycin
Area of Science:
- Dermatology
- Infectious Diseases
Background:
- Impetigo is a common, contagious bacterial skin infection.
- It typically presents as bullous or non-bullous forms.
- Caused by Staphylococcus aureus and/or group A Streptococcus.
Observation:
- An unusual case of pustular impetigo is presented.
- The patient was a 35-year-old man with symmetrical groin pustules.
- Exfoliative toxins from Staphylococcus aureus cause bulla formation in bullous impetigo.
Findings:
- The patient's pustular impetigo was successfully treated with clarithromycin.
- Clarithromycin is generally a second-line therapy for bullous impetigo.
- This case demonstrates the efficacy of clarithromycin in an unusual impetigo presentation.
Implications:
- Clarithromycin may be an effective treatment option for certain impetigo presentations.
- This case expands the understanding of impetigo treatment.
- Further research may explore clarithromycin's role in impetigo management.